Katherine Kay

525 total citations
21 papers, 334 citations indexed

About

Katherine Kay is a scholar working on Public Health, Environmental and Occupational Health, Computational Theory and Mathematics and Infectious Diseases. According to data from OpenAlex, Katherine Kay has authored 21 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Public Health, Environmental and Occupational Health, 11 papers in Computational Theory and Mathematics and 4 papers in Infectious Diseases. Recurrent topics in Katherine Kay's work include Malaria Research and Control (17 papers), Computational Drug Discovery Methods (11 papers) and Mosquito-borne diseases and control (9 papers). Katherine Kay is often cited by papers focused on Malaria Research and Control (17 papers), Computational Drug Discovery Methods (11 papers) and Mosquito-borne diseases and control (9 papers). Katherine Kay collaborates with scholars based in United Kingdom, United States and Switzerland. Katherine Kay's co-authors include Ian M. Hastings, Eva Maria Hodel, Robert R. Bies, Dhaval K. Shah, Nakul Chitnis, Susana Barbosa, Peter Pemberton‐Ross, Thomas A. Smith, Melissa A. Penny and Lisa C. Rohan and has published in prestigious journals such as Scientific Reports, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Katherine Kay

21 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katherine Kay United Kingdom 12 266 117 58 50 33 21 334
Dennis W. Juma Kenya 10 245 0.9× 92 0.8× 41 0.7× 29 0.6× 42 1.3× 21 277
Khadidiatou Ba Fall Senegal 7 304 1.1× 99 0.8× 51 0.9× 26 0.5× 40 1.2× 7 309
Daniel A Nash United Kingdom 2 280 1.1× 82 0.7× 78 1.3× 55 1.1× 52 1.6× 4 315
Rhoda Masonga Malawi 3 318 1.2× 95 0.8× 75 1.3× 24 0.5× 46 1.4× 4 364
Aminatou Koné Mali 10 376 1.4× 125 1.1× 62 1.1× 33 0.7× 41 1.2× 21 396
Cheikhou Camara Senegal 7 314 1.2× 120 1.0× 40 0.7× 24 0.5× 44 1.3× 7 328
Anja Rippert Germany 6 198 0.7× 88 0.8× 43 0.7× 35 0.7× 80 2.4× 8 290
Irina Jovel Sweden 10 275 1.0× 69 0.6× 48 0.8× 21 0.4× 23 0.7× 14 286
Edwin Ochong United Kingdom 9 349 1.3× 102 0.9× 91 1.6× 41 0.8× 73 2.2× 10 395
Varakorn Kosaisavee Thailand 7 308 1.2× 39 0.3× 57 1.0× 44 0.9× 44 1.3× 10 323

Countries citing papers authored by Katherine Kay

Since Specialization
Citations

This map shows the geographic impact of Katherine Kay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine Kay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine Kay more than expected).

Fields of papers citing papers by Katherine Kay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine Kay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine Kay. The network helps show where Katherine Kay may publish in the future.

Co-authorship network of co-authors of Katherine Kay

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine Kay. A scholar is included among the top collaborators of Katherine Kay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine Kay. Katherine Kay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kay, Katherine, Justin Goodwin, Hanna Y. Ehrlich, et al.. (2022). Impact of Drug Exposure on Resistance Selection Following Artemether‐Lumefantrine Treatment for Malaria in Children With and Without HIV in Uganda. Clinical Pharmacology & Therapeutics. 113(3). 660–669. 4 indexed citations
2.
Hastings, Ian M., Diggory Hardy, Katherine Kay, & Raman Sharma. (2020). Incorporating genetic selection into individual‐based models of malaria and other infectious diseases. Evolutionary Applications. 13(10). 2723–2739. 6 indexed citations
3.
4.
Kay, Katherine, et al.. (2020). Modeling HIV Pre-Exposure Prophylaxis. Frontiers in Pharmacology. 10. 1514–1514. 6 indexed citations
5.
Kay, Katherine, Eva Maria Hodel, Aimable Mbituyumuremyi, et al.. (2019). Improving Methods for Analyzing Antimalarial Drug Efficacy Trials: Molecular Correction Based on Length-Polymorphic Markers msp-1 , msp-2 , and glurp. Antimicrobial Agents and Chemotherapy. 63(9). 16 indexed citations
6.
Kay, Katherine, et al.. (2019). Estimation of Solid Tumor Doubling Times from Progression-Free Survival Plots Using a Novel Statistical Approach. The AAPS Journal. 21(2). 27–27. 32 indexed citations
7.
Barbosa, Susana, Katherine Kay, Nakul Chitnis, & Ian M. Hastings. (2018). Modelling the impact of insecticide-based control interventions on the evolution of insecticide resistance and disease transmission. Parasites & Vectors. 11(1). 482–482. 25 indexed citations
8.
Hodel, Eva Maria, et al.. (2018). Optimal Treatments for Severe Malaria and the Threat Posed by Artemisinin Resistance. The Journal of Infectious Diseases. 219(8). 1243–1253. 7 indexed citations
9.
Kay, Katherine, Dhaval K. Shah, Lisa C. Rohan, & Robert R. Bies. (2018). Physiologically‐based pharmacokinetic model of vaginally administered dapivirine ring and film formulations. British Journal of Clinical Pharmacology. 84(9). 1950–1969. 19 indexed citations
10.
Hodel, Eva Maria, Katherine Kay, & Ian M. Hastings. (2016). Incorporating Stage-Specific Drug Action into Pharmacological Modeling of Antimalarial Drug Treatment. Antimicrobial Agents and Chemotherapy. 60(5). 2747–2756. 17 indexed citations
11.
Aljayyoussi, Ghaith, Katherine Kay, Stephen A. Ward, & Giancarlo A. Biagini. (2016). OptiMal-PK: an internet-based, user-friendly interface for the mathematical-based design of optimized anti-malarial treatment regimens. Malaria Journal. 15(1). 344–344. 1 indexed citations
12.
Hastings, Ian M., Eva Maria Hodel, & Katherine Kay. (2016). Quantifying the pharmacology of antimalarial drug combination therapy. Scientific Reports. 6(1). 32762–32762. 16 indexed citations
13.
Pemberton‐Ross, Peter, Thomas A. Smith, Eva Maria Hodel, Katherine Kay, & Melissa A. Penny. (2015). Age-shifting in malaria incidence as a result of induced immunological deficit: a simulation study. Malaria Journal. 14(1). 287–287. 26 indexed citations
14.
Kay, Katherine & Ian M. Hastings. (2015). Measuring windows of selection for anti-malarial drug treatments. Malaria Journal. 14(1). 292–292. 18 indexed citations
15.
Kay, Katherine, Eva Maria Hodel, & Ian M. Hastings. (2015). Altering Antimalarial Drug Regimens May Dramatically Enhance and Restore Drug Effectiveness. Antimicrobial Agents and Chemotherapy. 59(10). 6419–6427. 25 indexed citations
16.
Hastings, Ian M., Katherine Kay, & Eva Maria Hodel. (2015). How Robust Are Malaria Parasite Clearance Rates as Indicators of Drug Effectiveness and Resistance?. Antimicrobial Agents and Chemotherapy. 59(10). 6428–6436. 47 indexed citations
17.
18.
Kay, Katherine, Eva Maria Hodel, & Ian M. Hastings. (2014). Improving the Role and Contribution of Pharmacokinetic Analyses in Antimalarial Drug Clinical Trials. Antimicrobial Agents and Chemotherapy. 58(10). 5643–5649. 4 indexed citations
19.
Kay, Katherine & Ian M. Hastings. (2013). Improving Pharmacokinetic-Pharmacodynamic Modeling to Investigate Anti-Infective Chemotherapy with Application to the Current Generation of Antimalarial Drugs. PLoS Computational Biology. 9(7). e1003151–e1003151. 30 indexed citations
20.
Hodel, Eva Maria, Katherine Kay, Daniel M. Hayes, Dianne J. Terlouw, & Ian M. Hastings. (2012). An in silico drug treatment model to assess the robustness of regional age-based dosing regimens for artemisinin-based combination therapies. Malaria Journal. 11(S1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dennis W. Juma Breakdown of academic impact, for papers by Khadidiatou Ba Fall Breakdown of academic impact, for papers by Daniel A Nash Breakdown of academic impact, for papers by Rhoda Masonga Breakdown of academic impact, for papers by Aminatou Koné Breakdown of academic impact, for papers by Cheikhou Camara Breakdown of academic impact, for papers by Anja Rippert Breakdown of academic impact, for papers by Irina Jovel Breakdown of academic impact, for papers by Edwin Ochong Breakdown of academic impact, for papers by Varakorn Kosaisavee
Rankless by CCL
2026